Brain Biomarkers Market
Brain Biomarkers Market By Product Type, Disease Indication, Application, End use & Region - Forecast 2022 – 2032
Market Insights on Brain Biomarkers covering sales outlook, demand forecast and up-to-date key trends
Brain Biomarkers Market Snapshot (2022-2032)
[250 Pages Report] The global brain biomarkers market is anticipated to exhibit growth at a CAGR of 14.3% in the forecast period from 2022 to 2032. It is set to reach US$ 8.3 Billion in 2022 and US$ 11.5 Billion in 2032. The rising prevalence of various neurological diseases, such as brain tumors, migraines, epilepsy, and dementia is projected to drive the sales of brain biomarkers in future years.
Report Attribute |
Details |
Brain Biomarkers Market Estimated Base Year Value (2021) |
US$ 7.1 Billion |
Brain Biomarkers Market Expected Market Value (2022) |
US$ 8.3 Billion |
Brain Biomarkers Market Anticipated Forecast Value (2032) |
US$ 11.5 Billion |
Brain Biomarkers Market Projected Growth Rate (2022-2032) |
14.3% CAGR |
Biomarkers are referred to as molecules that indicate the presence of a dysfunction or disease. These are becoming increasingly important for monitoring disease progression, selecting the best treatments, and confirming diagnoses.
Neurological biomarkers are mainly present in Cerebrospinal Fluid (CSF) and rarely in blood. These can be studied by using CSF, but require an invasive lumbar puncture procedure.
Biomarker signatures are considered to be another powerful tool for studying neurological conditions and diseases. These are detected with the help of panels of high-quality antibodies.
The development of genomic biomarkers is projected to create new opportunities for the introduction of diagnostics that are based on a person’s specific genetic variations. Genomic biomarkers are also expected to help in the creation of personalized medicines.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Which are Some Major Factors Spurring Growth of the Brain Biomarkers Market
The ongoing technological advancement in the field of biomarkers and the emergence of biomarker signatures are expected to make neurological diseases more treatable. This is further expected to result in the early diagnosis, faster drug development, and non-invasive testing.
The launch of digital biomarkers by key players is set to deliver numerous pharmaceutical companies supplemental and contextual information to conclude clinical trials efficiently. Besides, government funding to accelerate research and development activities in various countries is expected to propel the demand for brain biomarkers in the assessment period.
Which Factors May Restrain the Brain Biomarkers Market Growth
The usage of brain biomarkers is limited to researchers for better understanding the disease progression. Several pharmaceutical and pathology companies worldwide are also using these to rapidly develop new therapeutics for neurodegenerative disorders. The lack of availability of commercial or direct-to-consumer tests may hamper the brain biomarkers market size in the near future.
Why is North America Projected to Dominate the Brain Biomarkers Market
North America is anticipated to lead in terms of the brain biomarkers market share during the forthcoming years. This growth is attributable to the rising research funding by regulatory bodies and the surging acceptance of biomarkers for drug development purposes in the U.S. and Canada.
The increasing prevalence of various neurological diseases across these developed countries is another significant factor that is estimated to augur well for the market.
As per the Centers for Disease Control and Prevention (CDC), at present, nearly 5.8 million people have Alzheimer’s disease in the U.S. Cases of Alzheimer’s disease are expected to reach 14 million by 2060 in the country. These numbers are projected to grow at a fast pace, thereby propelling the North America market.
How is the Asia Pacific Brain Biomarkers Market Progressing
Asia Pacific is likely to exhibit a CAGR of 15.4% in the forecast period from 2022 to 2032. The rising number of clinical trials that are being conducted in China, Japan, India, and South Korea is projected to drive the Asia Pacific brain biomarkers market growth in future years.
The surging demand for targeted drugs to treat conditions associated with the central nervous system is another vital factor that is anticipated to augment the growth in the regional market. According to the National Health Portal, in India, the prevalence of dementia is set to be around 2.7%. This condition poses a great challenge in the country owing to the surging geriatric population. This factor is also expected to fuel the regional market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Market Competition
Majority of the key players operating in the global market are striving to incorporate the latest technologies to make it easier for researchers to track the condition of the brain by measuring its molecules. They are consistently developing innovative brain testing methods to provide new treatment options and enable faster diagnosis. Meanwhile, a few other key players are aiming to invest huge sums in clinical trials to boost new product development.
Some of the leading companies present in the global brain biomarkers market include Siemens Healthineers, Electrical Geodesics, Lifesign LLC, Advanced Brain Monitoring, BrainScope, GE Healthcare, Johnson & Johnson, Natus Medical, F. Hoffmann-La Roche Ltd., Qiagen N.V., Nexus-DX, and NeuroVista among others.
Report Scope
Report Attribute |
Details |
Growth Rate |
CAGR of 14.3% from 2022 to 2032 |
Base Year for Estimation |
2021 |
Historical Data |
2015-2020 |
Forecast Period |
2022-2032 |
Quantitative Units |
Revenue in USD Million and CAGR from 2022-2032 |
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization |
Available Upon Request |
Key Segments Profiled in the Brain Biomarkers Industry Survey
By Product Type:
- Biomarker Test Kits
- Biomarker Analyzers
By Disease Indication:
- Stroke
- MND & ALS
- Alzheimer’s Disease & Other Dementias
- Parkinson’s Disease
- Huntington’s Disease
By Application:
- Diagnosis
- Drug Discovery and Development
- Others
By End User:
- Hospitals
- Research Laboratories
- Ambulatory Surgical Centers
- Diagnostic Laboratories
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- APEJ
- Japan
- Middle East and Africa
Frequently Asked Questions
At what rate will the brain biomarkers market grow?
The global brain biomarkers market is anticipated to surpass US$ 11.5 Billion in 2032.
Which region is set to lead the brain biomarkers market?
North America is set to lead the brain biomarkers market in the forecast period.
Which are some of the renowned companies in the brain biomarkers market?
Siemens Healthineers, Electrical Geodesics, Lifesign LLC, Advanced Brain Monitoring, BrainScope, GE Healthcare, and Johnson & Johnson are some of the renowned companies in the brain biomarkers market.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. Value Chain Analysis 3.5.1. Profit Margin Analysis 3.5.2. Service Providers 3.6. PESTLE and Porter’s Analysis 3.7. Regulatory Landscape 3.7.1. By Key Regions 3.7.2. By Key Countries 3.8. Regional Parent Market Outlook 4. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Biomarkers 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Biomarkers, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Biomarkers, 2022-2032 5.3.1. Genomics Biomarkers 5.3.2. Proteomic Biomarkers 5.3.3. Metabolomics Biomarkers 5.3.4. Imaging Biomarkers 5.3.5. Other Biomarkers 5.4. Y-o-Y Growth Trend Analysis By Biomarkers, 2017-2021 5.5. Absolute $ Opportunity Analysis By Biomarkers, 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032 6.3.1. Alzheimer’s Disease 6.3.2. Parkinson’s Disease 6.3.3. Huntington’s Disease 6.3.4. Schizophrenia 6.3.5. Depression 6.3.6. Multiple Sclerosis 6.3.7. Spinal Muscular Atrophy 6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021 6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By End Users 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By End Users, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Users, 2022-2032 7.3.1. Academic & Research Institutes 7.3.2. Diagnostic Laboratories 7.3.3. Hospitals 7.4. Y-o-Y Growth Trend Analysis By End Users, 2017-2021 7.5. Absolute $ Opportunity Analysis By End Users, 2022-2032 Deep-dive segmentation will be available in the sample on request 8. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia & Pacific 8.3.6. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Biomarkers 9.2.3. By Indication 9.2.4. By End Users 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Biomarkers 9.3.3. By Indication 9.3.4. By End Users 9.4. Key Takeaways 10. Latin America Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Mexico 10.2.1.2. Brazil 10.2.1.3. Rest of Latin America 10.2.2. By Biomarkers 10.2.3. By Indication 10.2.4. By End Users 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Biomarkers 10.3.3. By Indication 10.3.4. By End Users 10.4. Key Takeaways 11. Europe Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. U.K. 11.2.1.5. Spain 11.2.1.6. BENELUX 11.2.1.7. Russia 11.2.1.8. Rest of Europe 11.2.2. By Biomarkers 11.2.3. By Indication 11.2.4. By End Users 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Biomarkers 11.3.3. By Indication 11.3.4. By End Users 11.4. Key Takeaways 12. East Asia Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Biomarkers 12.2.3. By Indication 12.2.4. By End Users 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Biomarkers 12.3.3. By Indication 12.3.4. By End Users 12.4. Key Takeaways 13. South Asia & Pacific Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. ASEAN 13.2.1.3. Australia and New Zealand 13.2.1.4. Rest of South Asia & Pacific 13.2.2. By Biomarkers 13.2.3. By Indication 13.2.4. By End Users 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Biomarkers 13.3.3. By Indication 13.3.4. By End Users 13.4. Key Takeaways 14. MEA Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. Turkey 14.2.1.3. South Africa 14.2.1.4. Rest of MEA 14.2.2. By Biomarkers 14.2.3. By Indication 14.2.4. By End Users 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Biomarkers 14.3.3. By Indication 14.3.4. By End Users 14.4. Key Takeaways 15. Key Countries Brain Biomarkers Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Biomarkers 15.1.2.2. By Indication 15.1.2.3. By End Users 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Biomarkers 15.2.2.2. By Indication 15.2.2.3. By End Users 15.3. Mexico 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Biomarkers 15.3.2.2. By Indication 15.3.2.3. By End Users 15.4. Brazil 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Biomarkers 15.4.2.2. By Indication 15.4.2.3. By End Users 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Biomarkers 15.5.2.2. By Indication 15.5.2.3. By End Users 15.6. Italy 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Biomarkers 15.6.2.2. By Indication 15.6.2.3. By End Users 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Biomarkers 15.7.2.2. By Indication 15.7.2.3. By End Users 15.8. U.K. 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Biomarkers 15.8.2.2. By Indication 15.8.2.3. By End Users 15.9. Spain 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Biomarkers 15.9.2.2. By Indication 15.9.2.3. By End Users 15.10. BENELUX 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Biomarkers 15.10.2.2. By Indication 15.10.2.3. By End Users 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Biomarkers 15.11.2.2. By Indication 15.11.2.3. By End Users 15.12. China 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Biomarkers 15.12.2.2. By Indication 15.12.2.3. By End Users 15.13. Japan 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Biomarkers 15.13.2.2. By Indication 15.13.2.3. By End Users 15.14. South Korea 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Biomarkers 15.14.2.2. By Indication 15.14.2.3. By End Users 15.15. India 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Biomarkers 15.15.2.2. By Indication 15.15.2.3. By End Users 15.16. ASEAN 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Biomarkers 15.16.2.2. By Indication 15.16.2.3. By End Users 15.17. Australia and New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Biomarkers 15.17.2.2. By Indication 15.17.2.3. By End Users 15.18. GCC Countries 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Biomarkers 15.18.2.2. By Indication 15.18.2.3. By End Users 15.19. Turkey 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Biomarkers 15.19.2.2. By Indication 15.19.2.3. By End Users 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Biomarkers 15.20.2.2. By Indication 15.20.2.3. By End Users 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Biomarkers 16.3.3. By Indication 16.3.4. By End Users 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Merck KGaA 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Quanterix 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Myriad RBM 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. QIAGEN 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. ADx NeuroSciences NV 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Thermo Fisher Scientific 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. BioAgilytix 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. ACOBIOM 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Banyan Biomarkers, Inc. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Olink Biosciences 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. Illumina, Inc. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Region, 2017-2032 Table 2: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032 Table 3: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 4: Global Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032 Table 5: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 6: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032 Table 7: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 8: North America Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032 Table 9: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 10: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032 Table 11: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 12: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032 Table 13: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 14: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032 Table 15: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 16: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032 Table 17: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 18: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032 Table 19: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 20: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032 Table 21: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 22: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032 Table 23: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 24: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032 Table 25: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 26: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032 Table 27: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 28: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032 Table 29: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032 Table 30: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032 Table 31: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Table 32: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Table 33: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032 Table 34: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032 Table 35: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032 Table 36: MEA Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032 Table 37: MEA Brain Biomarkers Market Attractiveness by Indication, 2022-2032 Table 38: MEA Brain Biomarkers Market Attractiveness by End Users, 2022-2032 Table 39: MEA Brain Biomarkers Market Attractiveness by Country, 2022-2032
List of Charts
Figure 1: Global Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032 Figure 2: Global Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032 Figure 3: Global Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032 Figure 4: Global Brain Biomarkers Market Value (US$ Mn) by Region, 2022-2032 Figure 5: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Region, 2017-2032 Figure 6: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Region, 2022-2032 Figure 7: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Region, 2022-2032 Figure 8: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032 Figure 9: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032 Figure 10: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032 Figure 11: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 12: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 13: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 14: Global Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032 Figure 15: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032 Figure 16: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032 Figure 17: Global Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032 Figure 18: Global Brain Biomarkers Market Attractiveness by Indication, 2022-2032 Figure 19: Global Brain Biomarkers Market Attractiveness by End Users, 2022-2032 Figure 20: Global Brain Biomarkers Market Attractiveness by Region, 2022-2032 Figure 21: North America Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032 Figure 22: North America Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032 Figure 23: North America Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032 Figure 24: North America Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032 Figure 25: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 26: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 27: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 28: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032 Figure 29: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032 Figure 30: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032 Figure 31: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 32: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 33: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 34: North America Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032 Figure 35: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032 Figure 36: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032 Figure 37: North America Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032 Figure 38: North America Brain Biomarkers Market Attractiveness by Indication, 2022-2032 Figure 39: North America Brain Biomarkers Market Attractiveness by End Users, 2022-2032 Figure 40: North America Brain Biomarkers Market Attractiveness by Country, 2022-2032 Figure 41: Latin America Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032 Figure 42: Latin America Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032 Figure 43: Latin America Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032 Figure 44: Latin America Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032 Figure 45: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 46: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 47: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 48: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032 Figure 49: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032 Figure 50: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032 Figure 51: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 52: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 53: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 54: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032 Figure 55: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032 Figure 56: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032 Figure 57: Latin America Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032 Figure 58: Latin America Brain Biomarkers Market Attractiveness by Indication, 2022-2032 Figure 59: Latin America Brain Biomarkers Market Attractiveness by End Users, 2022-2032 Figure 60: Latin America Brain Biomarkers Market Attractiveness by Country, 2022-2032 Figure 61: Europe Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032 Figure 62: Europe Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032 Figure 63: Europe Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032 Figure 64: Europe Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032 Figure 65: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 66: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 67: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 68: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032 Figure 69: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032 Figure 70: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032 Figure 71: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 72: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 73: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 74: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032 Figure 75: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032 Figure 76: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032 Figure 77: Europe Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032 Figure 78: Europe Brain Biomarkers Market Attractiveness by Indication, 2022-2032 Figure 79: Europe Brain Biomarkers Market Attractiveness by End Users, 2022-2032 Figure 80: Europe Brain Biomarkers Market Attractiveness by Country, 2022-2032 Figure 81: East Asia Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032 Figure 82: East Asia Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032 Figure 83: East Asia Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032 Figure 84: East Asia Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032 Figure 85: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 86: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 87: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 88: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032 Figure 89: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032 Figure 90: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032 Figure 91: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 92: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 93: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 94: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032 Figure 95: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032 Figure 96: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032 Figure 97: East Asia Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032 Figure 98: East Asia Brain Biomarkers Market Attractiveness by Indication, 2022-2032 Figure 99: East Asia Brain Biomarkers Market Attractiveness by End Users, 2022-2032 Figure 100: East Asia Brain Biomarkers Market Attractiveness by Country, 2022-2032 Figure 101: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032 Figure 102: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032 Figure 103: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032 Figure 104: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032 Figure 105: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 106: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 107: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 108: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032 Figure 109: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032 Figure 110: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032 Figure 111: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 112: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 113: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 114: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032 Figure 115: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032 Figure 116: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032 Figure 117: South Asia & Pacific Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032 Figure 118: South Asia & Pacific Brain Biomarkers Market Attractiveness by Indication, 2022-2032 Figure 119: South Asia & Pacific Brain Biomarkers Market Attractiveness by End Users, 2022-2032 Figure 120: South Asia & Pacific Brain Biomarkers Market Attractiveness by Country, 2022-2032 Figure 121: MEA Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032 Figure 122: MEA Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032 Figure 123: MEA Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032 Figure 124: MEA Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032 Figure 125: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 126: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 127: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 128: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032 Figure 129: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032 Figure 130: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032 Figure 131: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 132: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 133: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 134: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032 Figure 135: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032 Figure 136: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032 Figure 137: MEA Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032 Figure 138: MEA Brain Biomarkers Market Attractiveness by Indication, 2022-2032 Figure 139: MEA Brain Biomarkers Market Attractiveness by End Users, 2022-2032 Figure 140: MEA Brain Biomarkers Market Attractiveness by Country, 2022-2032
Recommendations
Explore Healthcare Insights
View Reports